CYP2B6*6 genotype specific differences in artemether‐lumefantrine disposition in healthy volunteers
<p>Cytochrome P450 2B6 (CYP2B6) is involved in the metabolism of the antimalarial drugs artemether and lumefantrine. Here we investigated the effect of <em>CYP2B6</em>*6 on the plasma pharmacokinetics of artemether, lumefantrine, and their metabolites in healthy volunteers...
Hauptverfasser: | Abdullahi, ST, Soyinka, JO, Olagunju, A, Bolarinwa, RA, Olarewaju, OJ, Bakare-Odunola, MT, Winterberg, M, Tarning, J, Owen, A, Khoo, S |
---|---|
Format: | Journal article |
Sprache: | English |
Veröffentlicht: |
Wiley
2019
|
Ähnliche Einträge
Ähnliche Einträge
-
Differential impact of nevirapine on artemether-lumefantrine pharmacokinetics in individuals stratified by CYP2B6 c.516G>T genotypes
von: Abdullahi, ST, et al.
Veröffentlicht: (2020) -
Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine.
von: Ali, S, et al.
Veröffentlicht: (2010) -
Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine
von: Tarning Joel, et al.
Veröffentlicht: (2010-10-01) -
Drug interactions between dolutegravir and artemether-lumefantrine or artesunate-amodiaquine
von: Walimbwa, S, et al.
Veröffentlicht: (2018) -
Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
von: Sileshi Belew, et al.
Veröffentlicht: (2020-04-01)